Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Impact of GLP-1 agonists on cardiovascular outcomes in patients with sickle cell anemia: A propensity score matched retrospective cohort study

Sam King, Swe Swe Hlaing, Colton Jones, Sarah Eidbo, Akshay Ratnani, Angimar Uriepero, Laith Alomari, Ariana Neely, Elvis Obomanu, Zachary Cohn

Blood (2025) 146 (Supplement 1): 6495.

https://doi.org/10.1182/blood-2025-6495

Published: 2025

Journal Articles

Real world outcomes analysing the use of glucocorticoids in patients with acute chest syndrome: A propensity score matched analysis from global federated health research network

Yajur Arya, Arshi Syal, Angimar Uriepero, Himil Mahadevia, Nitya Batra, Ewa Wysokinska, Gabor Varadi

Blood (2025) 146 (Supplement 1): 2675.

https://doi.org/10.1182/blood-2025-2675

Published: 2025

Journal Articles

Cardiovascular outcomes in CLL patients receiving GLP-1 agonists and BTK inhibitors: A global propensity-matched study

Angimar Uriepero, Jose Milano, Elio Rodriguez, Karecia Byfield, Arshi Syal, Yajur Arya, Gabor Varadi

Blood (2025) 146 (Supplement 1): 2774.

https://doi.org/10.1182/blood-2025-2774

Published: 2025

Journal Articles

Clinical outcomes in patients with multiple myeloma and antidepressant use: A retrospective cohort study

Akshay Ratnani, Thitiphan Srikulmontri, Riley Marotta, Andrew Geller, Angimar Uriepero, Sam King, John Leighton

Blood (2025) 146 (Supplement 1): 8136.

https://doi.org/10.1182/blood-2025-8136

Published: 2025

Journal Articles

Real world outcomes comparing the use of GLP-1 receptor agonists in patients with CML and comorbid obesity: A propensity score matched analysis from global federated health research network

Arshi Syal, Yajur Arya, Angimar Uriepero, Himil Mahadevia, Nitya Batra, Gabor Varadi

Blood (2025) 146 (Supplement 1): 4635.

https://doi.org/10.1182/blood-2025-4635

Published: 2025

Journal Articles

Age-related differences in outcomes and treatment patterns of iron deficiency anemia in patient's with crohn's disease

Karecia Byfield, Elvis Obomanu, Angimar Uriepero, Akshay Ratnani, Tinsae Anebo, Chidiebube Uwgu, Colton Jones, Ryan Mayo

Blood (2025) 146 (Supplement 1): 2901.

https://doi.org/10.1182/blood-2025-2901

Published: 2025

Journal Articles

Timing of tyrosine kinase inhibitor switching and long-term outcomes in chronic myeloid leukemia: A real-world comparative study

Chidiebube Ugwu, Muluken Megiso, Elvis Obomanu, Angimar Uriepero, Chidiebere Ezeh, Sam King, Nneoma Ubah, Gabor Varadi, Alankrita Taneja

Blood (2025) 146 (Supplement 1): 7945.

https://doi.org/10.1182/blood-2025-7945

Published: 2025

Journal Articles

One-year outcomes of daratumumab-based vs. non-daratumumab regimens in AL amyloidosis: A propensity-matched real-world study

Chidiebube Ugwu, Muluken Megiso, Elvis Obomanu, Angimar Uriepero, Tarfa Verinumbe, Chidiebere Ezeh, Nnamdi Omenuko, Kelechi Onyenemezu, Nneoma Ubah, Gabor Varadi, Alankrita Taneja

Blood (2025) 146 (Supplement 1): 6369.

https://doi.org/10.1182/blood-2025-6369

Published: 2025

Journal Articles

Acalabrutinib vs zanubrutinib as first-line therapy in CLL: A propensity score–matched study

Angimar Uriepero, Jose Milano, Valeria Ziegler, Akshay Ratnani, Gabor Varadi

Blood (2025) 146 (Supplement 1): 6333.

https://doi.org/10.1182/blood-2025-6333

Published: 2025

Journal Articles

Clinical outcomes of first-line venetoclax-based regimens vs second-generation BTK inhibitors in CLL/SLL: A retrospective cohort study

Angimar Uriepero, Jose Milano, Chidiebube Ugwu, Sam King, Gabor Varadi

Blood (2025) 146 (Supplement 1): 4540.

https://doi.org/10.1182/blood-2025-4540

Published: 2025

Journal Articles

Enhancing CAR-T Therapy in CLL By Modulating the Immunosuppressive Tumor Microenvironment: A Novel Approach with Significant Therapeutic Potential

Angimar Uriepero Palma, Melanie Mediavilla Varela, Maria Elena Marquez, Wael Gamal, Mohammad Ammad-ud-din, Pablo Oppezzo, Eva Sahakian, Javier Pinilla-Ibarz

Blood (2024) 144 (Supplement 1): 4607.

https://doi.org/10.1182/blood-2024-204892

Published: 2024

Journal Articles

Reprogramming CLL T-Cell Mitochondrial Fitness Using PI3K Inhibition for Enhancing CAR T-Cell Therapy

Wael Gamal, Nienke B. Goedhart, Helga Simon-Molas, Melanie Mediavilla Varela, Angimar Uriepero Palma, Fleur S. Peters, Eva Sahakian, Arnon P. Kater, Javier Pinilla-Ibarz

Blood (2024) 144 (Supplement 1): 4803.

https://doi.org/10.1182/blood-2024-210992

Published: 2024

Journal Articles

Identifying the Role of Endoplasmic Reticulum Stress in CLL T-Cell Dysfunction

Wael Gamal, Melanie Mediavilla Varela, Angimar Uriepero Palma, Mohammad Ammad Ud Din, Julio C. Chavez, Eva Sahakian, Paulo C. Rodriguez, Javier Pinilla-Ibarz

Blood (2024) 144 (Supplement 1): 1848.

https://doi.org/10.1182/blood-2024-210608

Published: 2024

Journal Articles

Targeting Inflammatory Pathways to Reverse Immunosuppressive Tumor Microenvironment in Chronic Lymphocytic Leukemia

Angimar Uriepero, Melanie Mediavilla-Varela, Kamira Maharaj, Wael Gamal, Maria Elena Marquez, John J. Powers, Vishaal Kunta, Eva Sahakian, Pablo Oppezzo, Javier Pinilla Ibarz

Blood (2022) 140 (Supplement 1): 6988–6989.

https://doi.org/10.1182/blood-2022-167331

Published: 2022

Journal Articles

Metabolic Abnormalities Associated with T-Cell Exhaustion in CLL Eµ-TCL1 Murine Model

Wael Gamal, Melanie Mediavilla-Varela, Kamira Maharaj, Angimar Uriepero, Vishaal Kunta, Eva Sahakian, Javier Pinilla Ibarz

Blood (2022) 140 (Supplement 1): 6994–6995.

https://doi.org/10.1182/blood-2022-166704

Published: 2022

Journal Articles

Efficacy of Vecabrutinib Treatment in a Murine Model of Sclerodermatous Graft-Versus-Host-Disease

Kamira Maharaj, Melanie Mediavilla-Varela, Angimar Uriepero, Judith A. Fox, Pietro Taverna, Wael Gamal, Eva Sahakian, Javier Pinilla Ibarz

Blood (2021) 138 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2021-150598

Published: 2021

Journal Articles

Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia

Pablo Elías Morande, Mariela Sivina, Angimar Uriepero, Noé Seija, Catalina Berca, Pablo Fresia, Ana Inés Landoni, Javier M. Di Noia, Jan A. Burger, Pablo Oppezzo

Blood (2019) 133 (19): 2056–2068.

https://doi.org/10.1182/blood-2018-09-876292

Published: 2019

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impact of GLP-1 agonists on cardiovascular outcomes in patients with sickle cell anemia: A propensity score matched retrospective cohort study

Real world outcomes analysing the use of glucocorticoids in patients with acute chest syndrome: A propensity score matched analysis from global federated health research network

Cardiovascular outcomes in CLL patients receiving GLP-1 agonists and BTK inhibitors: A global propensity-matched study

Clinical outcomes in patients with multiple myeloma and antidepressant use: A retrospective cohort study

Real world outcomes comparing the use of GLP-1 receptor agonists in patients with CML and comorbid obesity: A propensity score matched analysis from global federated health research network

Age-related differences in outcomes and treatment patterns of iron deficiency anemia in patient's with crohn's disease

Timing of tyrosine kinase inhibitor switching and long-term outcomes in chronic myeloid leukemia: A real-world comparative study

One-year outcomes of daratumumab-based vs. non-daratumumab regimens in AL amyloidosis: A propensity-matched real-world study

Acalabrutinib vs zanubrutinib as first-line therapy in CLL: A propensity score–matched study

Clinical outcomes of first-line venetoclax-based regimens vs second-generation BTK inhibitors in CLL/SLL: A retrospective cohort study

Enhancing CAR-T Therapy in CLL By Modulating the Immunosuppressive Tumor Microenvironment: A Novel Approach with Significant Therapeutic Potential

Reprogramming CLL T-Cell Mitochondrial Fitness Using PI3K Inhibition for Enhancing CAR T-Cell Therapy

Identifying the Role of Endoplasmic Reticulum Stress in CLL T-Cell Dysfunction

Targeting Inflammatory Pathways to Reverse Immunosuppressive Tumor Microenvironment in Chronic Lymphocytic Leukemia

Metabolic Abnormalities Associated with T-Cell Exhaustion in CLL Eµ-TCL1 Murine Model

Efficacy of Vecabrutinib Treatment in a Murine Model of Sclerodermatous Graft-Versus-Host-Disease

Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only